Methylphenidate improves weight control in childhood brain tumor survivors with hypothalamic obesity.

Vincent E HorneKevin BielamowiczJessica NguyenSusan HilsenbeckHolly LindsayRona SonabendAlexis C WoodFatih OkcuStephanie Sisley

Published in: Pediatric blood & cancer (2020)

Methylphenidate use reduced and sustained BMI change in children with hypothalamic obesity. Stimulant therapy is an effective first-line agent for treatment of hypothalamic obesity.

Keyphrases

weight gain
weight loss
insulin resistance
attention deficit hyperactivity disorder
metabolic syndrome
high fat diet induced
type diabetes
body mass index
young adults
physical activity
adipose tissue
stem cells
bone marrow
smoking cessation
childhood cancer
working memory